NCT00946387View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions

NauseaVomiting

Interventions

DRUG

Ondansetron HCl 24 mg Tablets (Sandoz, Inc.)

DRUG

Zofran (Ondansetron HCl) 24 mg Tablets (GlaxoSmithKline)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sandoz

INDUSTRY

NCT00946387 - To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter